SIC 2833 – Medicinal Chemicals and Botanical Products
Valuation | |
---|---|
Market Cap ($M) | 615.25 |
Enterprise Value ($M) | 344.28 |
Book Value ($M) | 262.19 |
Book Value / Share | 3.58 |
Price / Book | 2.35 |
NCAV ($M) | 241.78 |
NCAV / Share | 3.30 |
Price / NCAV | 2.54 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.34 |
Return on Assets (ROA) | -0.69 |
Return on Equity (ROE) | -1.02 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 9.00 |
Current Ratio | 9.00 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 299.36 |
Assets | 319.77 |
Liabilities | 57.58 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Commodore Capital Lp | 9.90 | 40.17 | |
13G | BlackRock, Inc. | 7.00 | 0.00 | |
13G | Deep Track Capital, LP | 9.49 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
1,065,726 | 5,024,170 | 21.21 | |
670,045 | 1,922,524 | 34.85 | |
257,291 | 1,319,071 | 19.51 | |
324,789 | 2,286,294 | 14.21 | |
449,706 | 2,687,646 | 16.73 | |
(click for more detail) |
Similar Companies | |
---|---|
MGTX – MeiraGTx Holdings plc | MIST – Milestone Pharmaceuticals Inc. |
MLYS – Mineralys Therapeutics, Inc. | MRNA – Moderna, Inc. |
MRSN – Mersana Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io